
MK-3328
CAS No. 1201323-97-8
MK-3328( —— )
Catalog No. M33432 CAS No. 1201323-97-8
MK-3328 has a high affinity for β-Amyloid (IC50:10.5 nM), and can be used as a candidate PET ligand for clinical assessment of β-amyloid plaque load. MK-3328 is a potential treatment for Alzheimer's disease.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 532 | Get Quote |
![]() ![]() |
5MG | 787 | Get Quote |
![]() ![]() |
10MG | 1074 | Get Quote |
![]() ![]() |
25MG | 1463 | Get Quote |
![]() ![]() |
50MG | 1822 | Get Quote |
![]() ![]() |
100MG | 2250 | Get Quote |
![]() ![]() |
500MG | 4410 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameMK-3328
-
NoteResearch use only, not for human use.
-
Brief DescriptionMK-3328 has a high affinity for β-Amyloid (IC50:10.5 nM), and can be used as a candidate PET ligand for clinical assessment of β-amyloid plaque load. MK-3328 is a potential treatment for Alzheimer's disease.
-
DescriptionMK-3328 is a β-Amyloid PET ligand, which exhibits high binding potency with an IC50 of 10.5 nM.
-
In VitroMK-3328 exhibits amyloid binding potency balanced with low levels of nonspecific binding.
-
In VivoIn vivo, [18F]MK-3328 demonstrates favorable kinetics, exhibiting high brain uptake and good washout in normal rhesus monkey positron emission tomography (PET) imaging studies.
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetBeta Amyloid
-
RecptorBeta Amyloid
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1201323-97-8
-
Formula Weight268.25
-
Molecular FormulaC14H9FN4O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESFC=1N=C2OC(=NC2=CC1)C=3C=C4C(=NC3)N(C)C=C4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference



-
β-Amyloid (1-42), ra...
Amyloid (1-42), rat is a polypeptide composed of 42 amino acids. It is toxic to hippocampal slices and can be used in the study of alzheimer's disease.
-
RAGE antagonist pept...
Receptor for advanced glycation end products (RAGE) antagonist. Blocks S100P, S100A4 and HMGB-1 mediated RAGE activation in vitro and in vivo. Inhibits growth and metastasis of rat glioma tumors. Reduces cell growth and RAGE-mediated NF-κB activity in human PDAC cell lines. Inhibits effects of TDI exposure in BALB/c mice.
-
Sophoridine
Sophoridine, a natural anticancer drug, has been used in China for decades. A series of novel N-substituted Sophoridinic acid derivatives were synthesized and evaluated for their cytotoxicity with 1 as the lead.